Romil Expands UK Customer Support

News

Romil Expands UK Customer Support

01 Aug, 2019

Published over 6 years ago. See the latest and most current information on News.

Romil has appointed Paul Stubbings as its UK National Sales Manager to ensure the best possible service for its expanding UK customer base. This newly created role will help to ensure the highest level of customer service for UK customers, and allow Sales Director Anthony Lenk to dedicate more time to the company’s rapidly growing direct sales and distributor-based export markets. 

Paul brings a wealth of knowledge and strategic expertise to Romil, backed by a strong foundation in chemistry. Having started his career as an analytical chemist working with GC, ICP and HPLC – and using Romil products – Paul understands what customers need, and how best to deliver it. This is combined with many years of sales experience in the UK and internationally, working for or supplying companies such as Shimadzu, PerkinElmer, GSK and Pfizer, as well as a number of SMEs and start-ups. 

Paul commented: “I’m thrilled to be joining the Romil team at this exciting time. There is clearly a strong demand for the high quality products Romil offers; I’ve never worked for a company that gets so many contact requests from new customers before! My aim is to provide all our UIK customers - from big pharma to small university labs - with an exceptional level of service that matches the quality of Romil products.”

More information  online: www.romil.com

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
New laser-based PPM gas analysis for environmental monitoring
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
Three generations of innovation. One powerful new platform
Explore more Arrow
Chromatography Today
Wiley expands forensic drug database for faster identification of designer drugs
Explore more Arrow